{"id":"https://openalex.org/W2990301893","doi":"https://doi.org/10.1142/s0219633619500354","title":"In silico modeling and in vitro activity of vitexin and isovitexin against SGLT2","display_name":"In silico modeling and in vitro activity of vitexin and isovitexin against SGLT2","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2990301893","doi":"https://doi.org/10.1142/s0219633619500354","mag":"2990301893"},"language":"en","primary_location":{"id":"doi:10.1142/s0219633619500354","doi":"https://doi.org/10.1142/s0219633619500354","is_oa":false,"landing_page_url":"https://doi.org/10.1142/s0219633619500354","pdf_url":null,"source":{"id":"https://openalex.org/S165401249","display_name":"Journal of Theoretical and Computational Chemistry","issn_l":"0219-6336","issn":["0219-6336","1793-6888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310319815","host_organization_name":"World Scientific","host_organization_lineage":["https://openalex.org/P4310319815"],"host_organization_lineage_names":["World Scientific"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Theoretical and Computational Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016141225","display_name":"Yongheng Shi","orcid":"https://orcid.org/0000-0002-4290-2593","observed_orcids":["https://orcid.org/0000-0002-4290-2593"]},"institutions":[{"id":"https://openalex.org/I4405271309","display_name":"Shaanxi Administration of Traditional Chinese Medicine","ror":"https://ror.org/027hagy81","country_code":"CN","type":"government","lineage":["https://openalex.org/I4405271309"]},{"id":"https://openalex.org/I75920027","display_name":"Shaanxi University of Chinese Medicine","ror":"https://ror.org/021r98132","country_code":"CN","type":"education","lineage":["https://openalex.org/I75920027"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yongheng Shi","raw_affiliation_strings":["Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","Shaanxi University of Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China"],"raw_orcid":"https://orcid.org/0000-0002-4290-2593","affiliations":[{"raw_affiliation_string":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","institution_ids":["https://openalex.org/I4405271309"]},{"raw_affiliation_string":"Shaanxi University of Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","institution_ids":["https://openalex.org/I75920027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062865827","display_name":"Fancui Meng","orcid":"https://orcid.org/0000-0002-5064-0618","observed_orcids":["https://orcid.org/0000-0002-5064-0618"]},"institutions":[{"id":"https://openalex.org/I4210105139","display_name":"Tianjin Institute of Pharmaceutical Research (China)","ror":"https://ror.org/01g9y2x13","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210105139"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fancui Meng","raw_affiliation_strings":["Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, P.\u00a0R.\u00a0China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, P.\u00a0R.\u00a0China","institution_ids":["https://openalex.org/I4210105139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100716248","display_name":"Jiping Liu","orcid":"https://orcid.org/0000-0002-7558-0025","observed_orcids":["https://orcid.org/0000-0002-7558-0025"]},"institutions":[{"id":"https://openalex.org/I4405271309","display_name":"Shaanxi Administration of Traditional Chinese Medicine","ror":"https://ror.org/027hagy81","country_code":"CN","type":"government","lineage":["https://openalex.org/I4405271309"]},{"id":"https://openalex.org/I75920027","display_name":"Shaanxi University of Chinese Medicine","ror":"https://ror.org/021r98132","country_code":"CN","type":"education","lineage":["https://openalex.org/I75920027"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiping Liu","raw_affiliation_strings":["Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","Shaanxi University of Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","institution_ids":["https://openalex.org/I4405271309"]},{"raw_affiliation_string":"Shaanxi University of Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","institution_ids":["https://openalex.org/I75920027"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018669420","display_name":"Bin Wang","orcid":"https://orcid.org/0000-0002-4953-5239","observed_orcids":["https://orcid.org/0000-0002-4953-5239"]},"institutions":[{"id":"https://openalex.org/I4405271309","display_name":"Shaanxi Administration of Traditional Chinese Medicine","ror":"https://ror.org/027hagy81","country_code":"CN","type":"government","lineage":["https://openalex.org/I4405271309"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bin Wang","raw_affiliation_strings":["Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine, Shaanxi Administration of Traditional Chinese Medicine, Xianyang 712046, P.\u00a0R.\u00a0China","institution_ids":["https://openalex.org/I4405271309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5062865827"],"corresponding_institution_ids":["https://openalex.org/I4210105139"],"apc_list":null,"apc_paid":null,"fwci":0.0925,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.31652607,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"18","issue":"07","first_page":"1950035","last_page":"1950035"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.6201000213623047,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.6201000213623047,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.3206000030040741,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vitexin","display_name":"vitexin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/isovitexin","display_name":"isovitexin","score":1.0},{"id":"https://openalex.org/keywords/sglt2","display_name":"SGLT2","score":0.8600000143051147},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.8629999756813049},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.7559999823570251},{"id":"https://openalex.org/keywords/homology-modeling","display_name":"homology modeling","score":0.7200000286102295},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.9760000109672546},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8040000200271606},{"id":"https://openalex.org/keywords/antidiabetic-activity","display_name":"antidiabetic activity","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2779594952","wikidata":"https://www.wikidata.org/wiki/Q3155636","display_name":"Isovitexin","level":5,"score":0.9107909202575684},{"id":"https://openalex.org/C2779301978","wikidata":"https://www.wikidata.org/wiki/Q259075","display_name":"Vitexin","level":4,"score":0.9080626964569092},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.7085323333740234},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5507916212081909},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4829525351524353},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4223382771015167},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3507499098777771},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.25993090867996216},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25442448258399963},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.17808037996292114},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17565762996673584},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12481293082237244},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.12069886922836304},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.0},{"id":"https://openalex.org/C2779054382","wikidata":"https://www.wikidata.org/wiki/Q72185287","display_name":"Flavonoid","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1142/s0219633619500354","doi":"https://doi.org/10.1142/s0219633619500354","is_oa":false,"landing_page_url":"https://doi.org/10.1142/s0219633619500354","pdf_url":null,"source":{"id":"https://openalex.org/S165401249","display_name":"Journal of Theoretical and Computational Chemistry","issn_l":"0219-6336","issn":["0219-6336","1793-6888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310319815","host_organization_name":"World Scientific","host_organization_lineage":["https://openalex.org/P4310319815"],"host_organization_lineage_names":["World Scientific"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Theoretical and Computational Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320335970","display_name":"Scientific Research Plan Projects of Shaanxi Education Department","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1966078827","https://openalex.org/W1977486075","https://openalex.org/W1983648006","https://openalex.org/W1985588649","https://openalex.org/W1998501014","https://openalex.org/W2026609170","https://openalex.org/W2028658694","https://openalex.org/W2037651276","https://openalex.org/W2044172327","https://openalex.org/W2097775366","https://openalex.org/W2106340518","https://openalex.org/W2124029073","https://openalex.org/W2124840360","https://openalex.org/W2178509179","https://openalex.org/W2319252693","https://openalex.org/W2557280814","https://openalex.org/W2889308415"],"related_works":["https://openalex.org/W2178509179","https://openalex.org/W4247460395","https://openalex.org/W4361269731","https://openalex.org/W4413695724","https://openalex.org/W4405391652","https://openalex.org/W4414609268","https://openalex.org/W4416596862","https://openalex.org/W7165387489","https://openalex.org/W4365399254","https://openalex.org/W2170536985"],"abstract_inverted_index":{"The":[0,37,64,122],"homology":[1],"model":[2],"of":[3,68,99,103,108,124,136,147,151],"hSGLT2":[4,90],"(human":[5],"sodium":[6],"dependent":[7],"glucose":[8],"co-transporter":[9],"2)":[10],"was":[11],"used":[12],"as":[13,34],"a":[14],"target":[15],"for":[16,75],"diabetes":[17],"mellitus.":[18],"Molecular":[19],"docking":[20],"and":[21,29,43,70,101,126,138,142],"dynamics":[22],"simulations":[23],"were":[24],"carried":[25],"out":[26],"on":[27],"vitexin-":[28],"isovitexin-SGLT2":[30],"complexes":[31],"with":[32,85,94],"dapagliflozin":[33],"positive":[35],"control.":[36],"results":[38,81,123],"show":[39],"that":[40,53],"both":[41,54],"vitexin":[42,69,100,137],"isovitexin":[44,71,104,139],"have":[45],"weaker":[46],"binding":[47,66],"energies":[48],"compared":[49],"to":[50],"dapagliflozin,":[51],"indicating":[52],"ligands":[55],"may":[56,72,130],"exhibit":[57],"weak":[58,77],"anti-diabetic":[59,78],"effects":[60],"through":[61],"inhibiting":[62,134],"SGLT2.":[63],"poor":[65],"mode":[67],"be":[73],"responsible":[74],"their":[76],"effect.":[79],"These":[80],"are":[82],"in":[83,91,127],"accordance":[84],"the":[86,95,106,132,148],"inhibitory":[87,96],"activity":[88],"against":[89,140],"vitro":[92,128],"test":[93,129],"rate":[97],"26.3%":[98],"11.2%":[102],"at":[105],"dose":[107],"10[Formula:":[109],"see":[110,112,114,116,118,120],"text][Formula:":[111,115,117],"text]mol[Formula:":[113],"text]L[Formula:":[119],"text].":[121],"calculation":[125],"explain":[131],"possible":[133],"mechanism":[135],"SGLT2,":[141],"therefore":[143],"enhance":[144],"our":[145],"understanding":[146],"structure-activity":[149],"relationships":[150],"SGLT2":[152],"inhibitors.":[153]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2019-12-05T00:00:00"}